1-20 of 21
Alan W. Partin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 129: Biobanking and feasibility considerations for prostate cancer gastrointestinal microbiome studies

Sarah E. Ernst, Mark C. Markowski, Anuj Gupta, Sarah J. Wheelan, H. Ballentine Carter, Alan W. Partin, Cynthia L. Sears, Karen S. Sfanos
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 129.
https://doi.org/10.1158/1538-7445.AM2018-129
Published: 01 July 2018
View article titled, Abstract 129: Biobanking and feasibility considerations for prostate cancer gastrointestinal microbiome studies
Journal Articles

Abstract 452: MIC-1 and Endoglin are protein serum biomarkers capable of increasing the clinical diagnostic specificity of the PSA test

Luciane T. Kagohara, Ji Li, Christian P. Pavlovich, Christine Davis, Leslie Mangold, Guangjing Zhu, Colm Morrissey, Alan W. Partin, Wlodeck Mandecki, Robert W. Veltri
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 452.
https://doi.org/10.1158/1538-7445.AM2016-452
Published: 15 July 2016
View article titled, Abstract 452: MIC-1 and Endoglin are protein serum biomarkers capable of increasing the clinical diagnostic specificity of the PSA test
Journal Articles

Abstract 3640: Overexpression of five novel biomarkers in human prostate tissues and cell lines

Christhunesa S. Christudass, Robert W. Veltri, Andrew Lelin, Eileen Chai, Angelo De Marzo, Alan W. Partin
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3640.
https://doi.org/10.1158/1538-7445.AM2012-3640
Published: 15 April 2012
View article titled, Abstract 3640: Overexpression of five novel biomarkers in human prostate tissues and cell lines
Journal Articles

Abstract 2731: Serum prostate health index and biopsy tissue DNA content at the time of diagnosis predicts the need for treatment in men enrolled in an active surveillance program

Sumit Isharwal, Danil Makarov, Lori J. Sokoll, Patricia Landis, Cameron Marlow, Jonathan I. Epstein, Alan W. Partin, H. Ballentine Carter, Robert W. Veltri
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2731.
https://doi.org/10.1158/1538-7445.AM10-2731
Published: 15 April 2010
View article titled, Abstract 2731: Serum prostate health index and biopsy tissue DNA content at the time of diagnosis predicts the need for treatment in men enrolled in an active surveillance program
Journal Articles

Abstract 2236: Nuclear roundness variance predicts prostate cancer progression, metastasis and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy

Robert W. Veltri, Sumit Isharwal, Craig Miller, Jonathan I. Epstein, Alan W. Partin
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2236.
https://doi.org/10.1158/1538-7445.AM10-2236
Published: 15 April 2010
View article titled, Abstract 2236: Nuclear roundness variance predicts prostate cancer progression, metastasis and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy
Journal Articles

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

Rong Hu, Thomas A. Dunn, Shuanzeng Wei, Sumit Isharwal, Robert W. Veltri, Elizabeth Humphreys, Misop Han, Alan W. Partin, Robert L. Vessella, William B. Isaacs, G. Steven Bova, Jun Luo
Journal: Cancer Research
Cancer Res (2009) 69 (1): 16–22.
https://doi.org/10.1158/0008-5472.CAN-08-2764
Published: 31 December 2008
View article titled, Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Open the PDF for Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Serum biomarkers for assessing risk of prostate cancer recurrence after radical retropubic prostatectomy.

Zhen Zhang, C. Nicole Ronsenzweig, Lorr J. Sokoll, Carol Cheli, Georg Bartsch, Richard J. Babaian, Wolfgang Horninger, Herbert A. Fritsche, Jr., Samir Taneja, Herbert Lepor, Stacey J. Childs, Thomas A. Stamey, Michael Brawer, Alan W. Partin, Eric T. Fung, Daniel W. Chan
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1240.
Published: 15 April 2006
View article titled, Serum biomarkers for assessing risk of prostate cancer recurrence after radical retropubic prostatectomy.
Journal Articles

Nuclear structure by semi-automated Iiage analysis classifies prostate cancer feulgen-stained nuclei captured from gleason graded tissue patterns.

Robert W. Veltri, Cameron Marlow, Jonathan I. Epstein, Massod A. Khan, Michael C. Miller, Alan W. Partin
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1240–1241.
Published: 15 April 2006
View article titled, Nuclear structure by semi-automated Iiage analysis classifies prostate cancer feulgen-stained nuclei captured from gleason graded tissue patterns.
Journal Articles

Improved prediction of PSA biochemical recurrence by quantitative nuclear grade (QNG) Using the NCI CPCTR-prostate tissue microarray.

Cameron Marlow, Alan W. Partin, Robert W. Veltri
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1242.
Published: 15 April 2006
View article titled, Improved prediction of PSA biochemical recurrence by quantitative nuclear grade (QNG) Using the NCI CPCTR-prostate tissue microarray.
Journal Articles

Identification of proteins associated with prostate cancer recurrence using proteomics approaches

C. Nicole White, Zhen Zhang, Derek Chappell, Jason M. Rosenzweig, Lori J. Sokoll, Alan W. Partin, Daniel W. Chan
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1131–1132.
Published: 01 May 2005
View article titled, Identification of proteins associated with prostate cancer recurrence using proteomics approaches
Journal Articles

Preoperative serum GSTP1 CpG island hypermethylation and the risk of early PSA recurrence following radical prostatectomy

Patrick J. Bastian, Ganesh S. Palapattu, Xiaohui Lin, Srinivasan Yegnasubramanian, Leslie A. Mangold, Bruce Trock, Alan W. Partin, William G. Nelson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 653.
Published: 01 May 2005
View article titled, Preoperative serum <em>GSTP1</em> CpG island hypermethylation and the risk of early PSA recurrence following radical prostatectomy
Journal Articles

PBOV1 (UC28): Molecular characterization and assessment as a serum marker for detection of prostate cancer (PCa)

Robert W. Veltri, Gunjan Malik, Elizabeth Rojahn, Cameron Marlow, Mike Ward, Alan W. Partin
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 743.
Published: 01 May 2005
View article titled, <em>PBOV1 (UC28):</em> Molecular characterization and assessment as a serum marker for detection of prostate cancer (PCa)
Journal Articles

A potential biomarker for prostate cancer detection and tumor grade prediction from a multicenter clinical proteomics study

Zhen Zhang, C. Nicole White, Carol Cheli, Eric T. Fung, Lori J. Sokoll, Alan W. Partin, Daniel W. Chan
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 742–743.
Published: 01 May 2005
View article titled, A potential biomarker for prostate cancer detection and tumor grade prediction from a multicenter clinical proteomics study
Journal Articles

Identification of SELDI-TOF over-expressed 17 kD protein in the Dunning metastatic prostate tumor model as Histone 2B (H2B).

Robert W. Veltri, Mathew B. Gretzer, Gunjan Malik, Michael Ward, Bao-Ling Adam, O. John Semmes, Cameron Van Rootselaar, Jason M. Rosenzweig, Daniel W. Chan, Alan W. Partin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 553.
Published: 01 April 2004
View article titled, Identification of SELDI-TOF over-expressed 17 kD protein in the Dunning metastatic prostate tumor model as Histone 2B (H2B).
Journal Articles

PBOV1 (UC28): A novel biomarker with potential utility in the management of prostate cancer

Robert W. Veltri, Cameron Van Rootselaar, Wesley Bales, Steven Bright, Alan W. Partin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 625.
Published: 01 April 2004
View article titled, <em>PBOV1</em> (UC28): A novel biomarker with potential utility in the management of prostate cancer
Journal Articles

Induction of Immunity to Prostate Cancer Antigens: Results of a Clinical Trial of Vaccination with Irradiated Autologous Prostate Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor Using ex Vivo Gene Transfer

Jonathan W. Simons, Bahar Mikhak, Ju-Fay Chang, Angelo M. DeMarzo, Michael A. Carducci, Michael Lim, Christine E. Weber, Angelo A. Baccala, Marti A. Goemann, Shirley M. Clift, Dale G. Ando, Hyam I. Levitsky, Lawrence K. Cohen, Martin G. Sanda, Richard C. Mulligan, Alan W. Partin, H. Ballentine Carter, Steven Piantadosi, Fray F. Marshall, William G. Nelson
Journal: Cancer Research
Cancer Res (1999) 59 (20): 5160–5168.
Published: 01 October 1999
View article titled, Induction of Immunity to Prostate Cancer Antigens: Results of a Clinical Trial of Vaccination with Irradiated Autologous Prostate Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor Using <em>ex Vivo</em> Gene Transfer
Open the PDF for Induction of Immunity to Prostate Cancer Antigens: Results of a Clinical Trial of Vaccination with Irradiated Autologous Prostate Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor Using <em>ex Vivo</em> Gene Transfer in another window
Journal Articles

Association of Glyceraldehyde-3-phosphate Dehydrogenase Expression with Cell Motility and Metastatic Potential of Rat Prostatic Adenocarcinoma

Daniel E. Epner, Alan W. Partin, Jack A. Schalken, John T. Isaacs, Donald S. Coffey
Journal: Cancer Research
Cancer Res (1993) 53 (9): 1995–1997.
Published: 01 May 1993
View article titled, Association of Glyceraldehyde-3-phosphate Dehydrogenase Expression with Cell Motility and Metastatic Potential of Rat Prostatic Adenocarcinoma
Open the PDF for Association of Glyceraldehyde-3-phosphate Dehydrogenase Expression with Cell Motility and Metastatic Potential of Rat Prostatic Adenocarcinoma in another window
Journal Articles

Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer

Alan W. Partin, Robert H. Getzenberg, Marne J. CarMichael, Don Vindivich, John Yoo, Jonathan I. Epstein, Donald S. Coffey
Journal: Cancer Research
Cancer Res (1993) 53 (4): 744–746.
Published: 01 February 1993
View article titled, Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer
Open the PDF for Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer in another window
Journal Articles

Cancer as a Disease of DNA Organization and Dynamic Cell Structure

Kenneth J. Pienta, Alan W. Partin, Donald S. Coffey
Journal: Cancer Research
Cancer Res (1989) 49 (10): 2525–2532.
Published: 01 May 1989
View article titled, Cancer as a Disease of DNA Organization and Dynamic Cell Structure
Open the PDF for Cancer as a Disease of DNA Organization and Dynamic Cell Structure in another window
Journal Articles

Early Cell Motility Changes Associated with an Increase in Metastatic Ability in Rat Prostatic Cancer Cells Transfected with the v-Harvey-ras Oncogene

Alan W. Partin, John T. Isaacs, Brent Treiger, Donald S. Coffey
Journal: Cancer Research
Cancer Res (1988) 48 (21): 6050–6053.
Published: 01 November 1988
View article titled, Early Cell Motility Changes Associated with an Increase in Metastatic Ability in Rat Prostatic Cancer Cells Transfected with the v-Harvey-<em>ras</em> Oncogene
Open the PDF for Early Cell Motility Changes Associated with an Increase in Metastatic Ability in Rat Prostatic Cancer Cells Transfected with the v-Harvey-<em>ras</em> Oncogene in another window